Last 48 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -3.01 | 74.04 | — | — | — | — | — | — | — | — | — | — | 257.92 | — | — | — | — | — | 6.33 | 62.38 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -82.5% | +30.7% | — | |
| P/S Ratio | 0.68 | 0.47 | 0.56 | 0.55 | 0.66 | 0.83 | 0.85 | 0.83 | 1.14 | 1.20 | 1.18 | 1.65 | 1.68 | 1.72 | 2.04 | 1.79 | 1.78 | 1.62 | 1.93 | 2.53 | 1.23 |
| — | -43.8% | -34.3% | -34.0% | -42.4% | -31.1% | -28.3% | -50.0% | -32.1% | -30.2% | -42.1% | -7.5% | -5.3% | +6.0% | +5.6% | -29.3% | +44.5% | -45.6% | -33.6% | +146.7% | +34.1% | |
| P/B Ratio | 1.03 | 0.69 | 0.88 | 0.87 | 1.01 | 0.90 | 0.74 | 0.71 | 1.00 | 0.73 | 0.75 | 1.03 | 0.89 | 0.84 | 1.01 | 0.84 | 0.84 | 0.73 | 0.87 | 0.82 | 1.08 |
| — | -22.7% | +18.3% | +23.3% | +1.5% | +23.3% | -1.8% | -31.6% | +11.7% | -12.8% | -25.6% | +22.3% | +6.3% | +14.2% | +15.8% | +3.0% | -22.0% | -21.2% | -8.2% | -2.7% | +27.5% | |
| P/FCF | 22.47 | 7.43 | 10.41 | — | 11.71 | 15.63 | 140.52 | — | 18.22 | 256.41 | — | — | 18.89 | 180.59 | — | — | — | — | — | — | 19.18 |
| — | -52.5% | -92.6% | — | -35.7% | -93.9% | — | — | -3.6% | +42.0% | — | — | — | — | — | — | — | — | — | — | +141.5% | |
| EV / EBITDA | 7.57 | 7.70 | 7.50 | 7.11 | 5.70 | 9.67 | 15.02 | 28.64 | — | 24.11 | 44.81 | 31.01 | 17.50 | 23.66 | 25.50 | 29.99 | 33.37 | 22.99 | 15.33 | 38.07 | 13.49 |
| — | -20.3% | -50.1% | -75.2% | — | -59.9% | -66.5% | -7.7% | — | +1.9% | +75.7% | +3.4% | -47.6% | +2.9% | +66.4% | -21.2% | +147.3% | -17.8% | -41.7% | +261.4% | +24.8% | |
| EV / EBIT | — | 82.71 | 42.77 | 33.62 | — | — | — | — | — | — | — | — | 74.70 | — | — | — | 225.11 | — | 7.20 | — | 29.39 |
| — | — | — | — | — | — | — | — | — | — | — | — | -66.8% | — | — | — | +665.9% | — | — | — | +28.5% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.8% | 60.8% | 61.6% | 54.9% | 60.7% | 52.2% | 59.3% | 59.5% | 54.8% | 56.7% | 55.0% | 57.7% | 58.1% | 58.2% | 58.0% | 57.9% | 56.7% | 56.2% | 54.6% | 54.8% | 40.9% |
| — | +16.4% | +4.0% | -7.6% | +10.7% | -7.9% | +7.8% | +3.0% | -5.7% | -2.6% | -5.1% | -0.3% | +2.5% | +3.5% | +6.1% | +5.5% | +38.6% | +2.3% | -3.0% | +29.9% | -4.5% | |
| Operating Margin | -0.8% | 0.6% | 3.0% | 3.4% | 8.4% | 1.6% | -2.8% | -7.7% | -118.5% | -6.3% | -8.4% | -6.8% | -1.3% | -4.9% | -3.4% | -6.1% | -6.9% | -4.7% | 1.4% | -8.2% | 5.4% |
| — | -63.3% | +204.9% | +144.8% | +107.1% | +126.2% | +66.2% | -13.2% | -9269.0% | -28.0% | -148.9% | -10.3% | +81.7% | -5.1% | -340.7% | +24.6% | -227.4% | -4.3% | +148.4% | -217.0% | -23.3% | |
| Net Margin | -52.7% | 0.6% | -0.2% | -1.5% | -90.4% | -104.1% | -6.5% | -10.0% | -125.4% | -6.2% | -3.5% | -13.9% | 0.7% | -0.7% | -2.3% | -5.7% | -9.4% | -17.4% | 19.5% | 4.0% | -0.2% |
| — | +100.5% | +96.9% | +85.1% | +27.9% | -1567.7% | -83.4% | +28.2% | -19347.4% | -804.5% | -52.2% | -142.6% | +106.9% | +96.0% | -112.0% | -243.3% | -4967.1% | -341.7% | +141.8% | +85.0% | -104.6% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -58.4% | 0.2% | -0.1% | -0.6% | -29.6% | -24.8% | -1.4% | -2.2% | -23.9% | -1.0% | -0.6% | -2.1% | 0.1% | -0.1% | -0.3% | -0.7% | -1.1% | -1.9% | 1.9% | 0.3% | -0.0% |
| — | +100.9% | +94.3% | +72.7% | -24.2% | -2505.8% | -150.1% | -0.9% | -27705.9% | -1038.8% | -94.8% | -215.8% | +107.7% | +95.7% | -115.3% | -309.1% | -2645.9% | -435.5% | +185.1% | -33.1% | -104.3% | |
| ROA | -27.7% | 0.1% | -0.0% | -0.2% | -12.6% | -12.1% | -0.7% | -1.2% | -13.7% | -0.6% | -0.3% | -1.4% | 0.1% | -0.1% | -0.2% | -0.5% | -0.9% | -1.5% | 1.2% | 0.2% | -0.0% |
| — | +100.7% | +95.8% | +80.4% | +8.1% | -2006.7% | -117.6% | +19.1% | -20699.1% | -781.0% | -49.3% | -164.7% | +107.5% | +95.6% | -119.3% | -407.2% | -3733.8% | -547.4% | +222.8% | -28.3% | -105.0% | |
| ROIC | -0.4% | 0.1% | 0.5% | 0.5% | 1.2% | 0.2% | -0.3% | -0.8% | -11.6% | -0.5% | -0.7% | -0.6% | -0.1% | -0.4% | -0.3% | -0.5% | -0.6% | -0.3% | 0.1% | -0.4% | 0.7% |
| — | -51.0% | +253.0% | +166.1% | +110.0% | +136.0% | +57.8% | -32.0% | -10334.0% | -28.1% | -150.8% | -23.3% | +80.0% | -14.9% | -445.7% | -33.8% | -182.5% | -75.3% | +163.2% | -147.7% | -10.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.92 | 0.90 | 0.93 | 0.95 | 0.92 | 0.71 | 0.57 | 0.56 | 0.55 | 0.42 | 0.43 | 0.43 | 0.16 | 0.14 | 0.14 | 0.10 | 0.10 | 0.15 | 0.15 | 0.48 | 0.46 |
| — | +26.0% | +63.1% | +71.2% | +68.9% | +67.8% | +31.7% | +30.5% | +249.2% | +214.0% | +216.5% | +311.4% | +61.6% | -12.3% | -9.8% | -78.6% | -79.1% | -60.1% | -62.8% | -12.8% | -30.9% | |
| Debt / EBITDA | 5.01 | 17.46 | 15.48 | 15.07 | 11.01 | 17.28 | 26.41 | 51.14 | — | 35.82 | 65.78 | 36.80 | 10.55 | 13.30 | 12.19 | 13.23 | 13.91 | 16.29 | 9.27 | 63.58 | 17.94 |
| — | +1.1% | -41.4% | -70.5% | — | -51.8% | -59.9% | +38.9% | — | +169.3% | +439.7% | +178.3% | -24.2% | -18.4% | +31.5% | -79.2% | -22.5% | -51.9% | -70.8% | +230.9% | -8.0% | |
| Current Ratio | 2.02 | 2.15 | 1.98 | 2.04 | 2.02 | 2.22 | 2.25 | 2.55 | 2.17 | 2.27 | 2.26 | 2.10 | 2.43 | 2.40 | 2.51 | 2.38 | 1.41 | 1.18 | 1.33 | 1.62 | 2.25 |
| — | -3.3% | -11.9% | -20.2% | -6.9% | -2.0% | -0.5% | +21.8% | -10.7% | -5.6% | -9.8% | -12.1% | +72.4% | +103.6% | +89.1% | +47.2% | -37.5% | -33.3% | -19.3% | +21.4% | +34.1% | |
| Quick Ratio | 1.04 | 1.08 | 1.00 | 1.05 | 1.04 | 1.16 | 1.15 | 1.32 | 1.13 | 1.12 | 1.08 | 1.03 | 1.16 | 1.08 | 1.23 | 1.13 | 0.65 | 0.69 | 0.83 | 1.03 | 1.90 |
| — | -6.6% | -12.7% | -21.0% | -8.2% | +3.5% | +6.6% | +28.8% | -2.1% | +3.7% | -12.1% | -8.8% | +77.5% | +55.8% | +47.1% | +9.4% | -65.7% | -28.5% | -8.1% | +9.2% | +93.7% | |
| Interest Coverage | -32.29 | 0.94 | 1.93 | 1.03 | -66.82 | -26.22 | -1.76 | -5.24 | -73.29 | -2.85 | -0.61 | -2.96 | 2.80 | -3.42 | -3.74 | -4.30 | 0.58 | -11.36 | 26.61 | -2.03 | 3.55 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ENOV stock.
Enovis Corporation's current P/E is -3.0x. The average P/E over the last 1 quarters is 74.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Enovis Corporation's current operating margin is -0.8%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Enovis Corporation's business trajectory between earnings reports.